Blocked autophagy by mir-101 enhances osteosarcoma cell chemosensitivity in vitro

Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Chang, Zhiqiang ^a,b   Huo, Lifeng ^b   Li, Kun ^c   Wu, Yiming ^b   Hu, Zhenming ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b INNER MONGOLIA MEDICAL UNIVERSITY   (China)

^c Chinese PLA 264 Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 5; DOXORUBICIN; MICRORNA 101; RAPAMYCIN; ANTINEOPLASTIC AGENT; MICRORNA; MIRN101 MICRORNA, HUMAN;

ARTICLE; AUTOPHAGY; CELL ORGANELLE; CELL VIABILITY; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MTT ASSAY; OSTEOSARCOMA CELL LINE; PROGNOSIS; PROTEIN EXPRESSION; WESTERN BLOTTING; CYTOPLASM VESICLE; DRUG EFFECTS; DRUG RESISTANCE; METABOLISM; OSTEOSARCOMA;

ANTINEOPLASTIC AGENTS; AUTOPHAGY; CYTOPLASMIC VESICLES; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; MICRORNAS; OSTEOSARCOMA;

EID: 84903555158     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/794756     Document Type: Article

References (26)

1. Ottaviani G., Jaffe N., The epidemiology of osteosarcoma. Pediatric and Adolescent Osteosarcoma 2010 Springer 3 13
2. Chou A. J., Geller D. S., Gorlick R., Therapy for osteosarcoma: where do we go from here? Pediatric Drugs 2008 10 5 315 327 2-s2.0-50649107280 10.2165/00148581-200810050-00005
3. Bacci G., Longhi A., Versari M., Mercuri M., Briccoli A., Picci P., Prognostic factors for osteosarcoma of the extremity trerated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006 106 5 1154 1161 2-s2.0-33644505791 10.1002/cncr.21724
4. Chou A. J., Merola P. B., Wexler L. H., Gorlick R. G., Vyas Y. M., Healey J. H., Laquaglia M. P., Huvos A. G., Meyers P. A., Treatment of osteosarcoma at first recurrence after contemporary therapy: the memorial sloan-kettering cancer center experience. Cancer 2005 104 10 2214 2221 2-s2.0-27644497180 10.1002/cncr.21417 (Pubitemid 41579969)
5. Deter R. L., de Duve C., Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes. The Journal of Cell Biology 1967 33 2 437 449 2-s2.0-0014083718
6. Jaeger P. A., Coray T. W., All-you-can-eat: autophagy in neurodegeneration and neuroprotection. Molecular Neurodegeneration 2009 4 1 16 38 2-s2.0-65549099222
7. Gibbings D., Mostowy S., Jay F., Schwab Y., Cossart P., Voinnet O., Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nature Cell Biology 2012 14 12 1314 1321 2-s2.0-84870601009 10.1038/ncb2611
8. Mathew R., Karantza-Wadsworth V., White E., Role of autophagy in cancer. Nature Reviews Cancer 2007 7 12 961 967 2-s2.0-36448943299 10.1038/nrc2254 (Pubitemid 350165856)
9. White E., DiPaola R. S., The double-edged sword of autophagy modulation in cancer. Clinical Cancer Research 2009 15 17 5308 5316 2-s2.0-69949106925 10.1158/1078-0432.CCR-07-5023
10. Korkaya H., Wicha M. S., Inflammation and autophagy conspire to promote tumor growth. Cell Cycle 2011 10 16 2623 2624 2-s2.0-80051727367 10.4161/cc.10.16.16414
11. Chen S., Jiang Y. Z., Huang L., Zhou R. J., Yu K. D., Liu Y., Shao Z. M., The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy. Clinical Cancer Research 2013 19 6853 6862
12. Chen S., Guan J. L., Tumor-promoting and -suppressive roles of autophagy in the same mouse model of BrafV600E-driven lung cancer. Cancer Discovery 2013 3 1225 1227
13. Gozuacik D., Kimchi A., Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004 23 16 2891 2906 2-s2.0-2442482810 10.1038/sj.onc. 1207521 (Pubitemid 38638851)
14. Huang J., Liu K., Yu Y., Xie M., Kang R., Vernon P., Cao L., Tang D., Ni J., Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy 2012 8 2 275 277 2-s2.0-84863767638
15. Osada H., Takahashi T., MicroRNAs in biological processes and carcinogenesis. Carcinogenesis 2007 28 1 2 12 2-s2.0-33845624889 10.1093/carcin/bgl185 (Pubitemid 44942621)
16. Lima R. T., Busacca S., Almeida G. M., Gaudino G., Fennell D. A., Vasconcelos M. H., MicroRNA regulation of core apoptosis pathways in cancer. European Journal of Cancer 2011 47 2 163 174 2-s2.0-78650686123 10.1016/j.ejca.2010.11.005
17. Frankel L. B., Lund A. H., MicroRNA regulation of autophagy. Carcinogenesis 2012 33 11 2018 2025 2-s2.0-84868627011 10.1093/carcin/bgs266
18. Frankel L. B., Wen J., Lees M., Høyer-Hansen M., Farkas T., Krogh A., Jäättelä M., Lund A. H., MicroRNA-101 is a potent inhibitor of autophagy. The EMBO Journal 2011 30 22 4628 4641 2-s2.0-81255143302 10.1038/emboj.2011.331
19. Bader A. G., Brown D., Stoudemire J., Lammers P., Developing therapeutic microRNAs for cancer. Gene Therapy 2011 18 12 1121 1126 2-s2.0-83255192141 10.1038/gt.2011.79
20. Thorsen S. B., Obad S., Jensen N. F., Stenvang J., Kauppinen S., The therapeutic potential of MicroRNAs in cancer. Cancer Journal 2012 18 3 275 284 2-s2.0-84862185932 10.1097/PPO.0b013e318258b5d6
21. Zou Z., Wu L., Ding H., Wang Y., Zhang Y., Chen X., Chen X., Zhang C., Zhang Q., Zen K., MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy. The Journal of Biological Chemistry 2012 287 6 4148 4156 2-s2.0-84863011747 10.1074/jbc.M111.307405
22. Wang P., Zhang J., Zhang L., Zhu Z., Fan J., Chen L., Zhuang L., Luo J., Chen H., Liu L., Chen Z., Meng Z., MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells. Gastroenterology 2013 145 1133.e12 1143.e12
23. Paglin S., Hollister T., Delohery T., Hackett N., McMahill M., Sphicas E., Domingo D., Yahalom J., A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Research 2001 61 2 439 444 2-s2.0-0035863399 (Pubitemid 32128593)
24. Daido S., Kanzawa T., Yamamoto A., Takeuchi H., Kondo Y., Kondo S., Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Research 2004 64 12 4286 4293 2-s2.0-3042562282 10.1158/0008-5472.CAN-03-3084 (Pubitemid 38802435)
25. Chou A. J., Gorlick R., Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert Review of Anticancer Therapy 2006 6 7 1075 1085 2-s2.0-33746450466 10.1586/14737140.6.7.1075 (Pubitemid 44203385)
26. Zhang Y., Hu H., Song L., Cai L., Wei R., Jin W., Epirubicin-mediated expression of miR-302b is involved in osteosarcoma apoptosis and cell cycle regulation. Toxicology Letters 2013 222 1 1 9 2-s2.0-84881113668 10.1016/j.toxlet.2013.06.242